2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Keyword Index<br />
ALL: P06.005, P06.177<br />
Allan-Herndon-Dudley: P11.069<br />
Allele specific PCR: P11.004<br />
alleles frequencies: P10.16<br />
Allelic association: P09.077<br />
allelic frequency: P09.019<br />
allelic imbalance: P06.098<br />
allelic losses: P06.099<br />
ALMS1: P16.01<br />
Alpers syndrome: P13.02<br />
alpha 1-antitrypsin: P11.005<br />
alpha fetoprotein: P05.01<br />
alpha globin gene: P12.010<br />
Alpha Synuclein: P17.58<br />
Alpha thalassemia: P02.170, P02.171,<br />
P12.010<br />
Alpha-1 antitrypsin (AAT),: P06.006,<br />
P10.02<br />
alpha-galactosidase A: P13.03<br />
alpha-synuclein: C12.2<br />
Alpha-Thalassemia: P02.172<br />
Alport syndrome: P02.007, P12.011,<br />
P12.012<br />
Alström syndrome: P12.013, P16.01<br />
alternative splicing: C01.2, P11.041<br />
Alu insertion/deletion polymorphism:<br />
P10.62, P17.39<br />
Alveolar capillary dysplasia: P02.008<br />
ALX: C04.3<br />
ALX3: C04.2<br />
Alzheimer´s disease: P03.004, P08.04,<br />
P08.05, P08.06, P09.024, P10.03,<br />
P12.015<br />
Alzheimer’s disease (AD) - early onset:<br />
P12.014<br />
ambiguous genitalia: P02.143, P03.201<br />
AMD: P10.04<br />
amelogenesis imperfecta: P02.026<br />
Amelogenin: P02.099<br />
Amenorrhea: P03.005<br />
amino acid: P13.43<br />
AML: C06.5, P06.069, P06.167, P06.168<br />
AMME syndrome: P02.009<br />
Amniocetesis: P05.24<br />
AMRF: P08.07<br />
Amyotrophic Lateral Sclerosis: S10.3<br />
Anatolian population.: P10.57, P10.82<br />
Anderson Fabry Disease: P13.03<br />
androgen receptor: P03.193, P12.016<br />
Anesthesia: P11.045<br />
aneuploidies: P05.53<br />
aneuploidy: C07.1, P03.006, P03.007,<br />
P03.016, P03.018, P03.045, P04.01,<br />
P04.32, P05.02, P05.59, P11.020<br />
Angelman syndrome: P03.170<br />
angiogenesis: P02.050, P09.044<br />
Angiotensin converting enzyme: P17.39,<br />
P17.45<br />
Anhidrotic ectodermal dysplasia: P12.017<br />
animal model: P17.66<br />
ANKRD1: C13.3<br />
Anomaly Dandy-Walker: P05.04<br />
anophthalmia-microphthalmia: P12.147<br />
Anorexia nervosa: P09.007<br />
Antihypertensive: P03.025<br />
aortic aneurysm: P08.08<br />
aortoliac occlusive disease: P08.43<br />
APC gene: P06.161<br />
APC: P06.158, P06.159, P06.160,<br />
P06.163<br />
APEX: P06.108<br />
aplastic anemia: P02.034<br />
aplastic breast: P02.095<br />
apoA1/C3/A5 gene cluster: P17.11<br />
ApoA5: P17.42<br />
APOC3: P08.09<br />
ApoE: P09.008, P17.34<br />
Apolipoprotein A5: P10.06<br />
Apolipoprotein B: P17.40<br />
apolipoprotein E polymorphism: P13.20<br />
Apolipoprotein E: P17.18<br />
Apoptosis: P03.197, P09.029, P14.09,<br />
P14.15<br />
APP, RUNX1, DIRK1A: P08.04<br />
ARCMT2: P12.101<br />
ARE sequences: P06.095<br />
Armenian patients: P08.28<br />
array CGH, SNP array: P03.082<br />
array CGH: C16.3, P03.076, P03.077,<br />
P03.083, P03.093, P03.099, P03.105,<br />
P03.162, P03.165, P05.54, P06.005,<br />
P06.167, PL2.4, S09.1<br />
array comparative genomic hybridization:<br />
P06.184<br />
Array Comparative Hybridization: C02.1<br />
arrayCGH: C07.5, C16.6, P03.079,<br />
P07.10, P11.006, S05.2<br />
Array-CGH: C16.2, P02.004, P02.084,<br />
P02.090, P02.155, P03.008, P03.040,<br />
P03.067, P03.068, P03.069, P03.084,<br />
P03.085, P03.086, P03.087, P03.088,<br />
P03.096, P03.097, P03.145, P03.161,<br />
P05.34, P05.42, P07.03<br />
arrhythmia syndromes: P16.05<br />
Arrhythmias: C13.6, P16.07<br />
Arrhythmogenic right ventricular<br />
cardiomyopathy: P16.09, P16.18<br />
ARRP: P12.018<br />
ARS: P12.107<br />
Arsenic: P03.009<br />
arterial anomalies: P02.092<br />
arterial hypertension: P17.14<br />
arterial ischemic stroke: P17.19<br />
arterial stiffness: P08.10<br />
Artrogryphosis: P02.073<br />
ARVC: P16.10<br />
ARX: P03.157<br />
Assisted reproductive technique: P05.47<br />
association study design: P08.13<br />
association study: P06.030, P08.11,<br />
P08.12, P08.20, P08.57, P08.63,<br />
P09.010, P09.012, P17.51, PL2.6<br />
association: C17.5, P06.076, P09.004,<br />
P09.009, P09.031, P09.067, P09.087,<br />
P09.109, P10.15, P11.047, P11.048<br />
associations: P08.64<br />
asthma: P02.010, P08.14, P09.011,<br />
P09.012, P10.48<br />
Ataxia telangiectasia: P12.019<br />
Ataxia type 10: P02.011<br />
ataxia: C03.3, P12.065, P17.59<br />
Ataxia-telangiectasia: P03.004<br />
ATGL: P10.05<br />
atherogenic dyslipidemia: P17.11<br />
Atherosclerosis: P17.18, P17.20, P17.40<br />
athletes: P09.013, P09.014, P09.015,<br />
P09.043, P09.044, P09.066, P09.129<br />
ATM gene: P12.019<br />
Atopic asthma: P10.07<br />
Atopic Eczema: P08.15, P09.016<br />
ATOX1: P13.49<br />
ATP1A3: P17.62<br />
ATP7B gene: P12.167<br />
ATP7B: P13.49<br />
Attention-Deficit Hyperactivity Disorder:<br />
P09.017<br />
ATXN10: P02.011<br />
ATXN2: P10.74<br />
atypical deletion: P03.183<br />
autism: P03.094, P09.018, P09.019,<br />
P09.112<br />
Autisme: P03.075<br />
Autoantibodies: P06.104<br />
autoimmune diseases: P15.01<br />
Autoimmune thyroid disease: P09.020<br />
autoimmune: C17.5<br />
automation: P03.052<br />
autophagy: P12.166<br />
autosomal dominant cardiomyopathy:<br />
P16.30<br />
Autosomal dominant congenital cataract:<br />
P12.020<br />
Autosomal dominant inheritance: P02.046,<br />
P02.154<br />
autosomal dominant optic atrophy:<br />
P12.082<br />
Autosomal dominant polycystic kidney<br />
disease: P12.021